Cargando…
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
BACKGROUND: Despite improvements in hemophilia care, challenges remain, including treatment burden and impaired quality of life. Gene therapy may overcome these. However, its introduction presents a challenge. OBJECTIVES: To outline a function-based gene therapy working model describing critical mil...
Autores principales: | Astermark, Jan, Baghaei, Fariba, Strandberg, Karin, Toplican, Petra Gabric, Birkedal, Maj Friberg, Grahn, Emma Engman, Hansson, Charlotta, Kampmann, Peter, Lehtinen, Anna-Elina, Täckström, Kinga, Holme, Pål Andre, Magnusson, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583513/ https://www.ncbi.nlm.nih.gov/pubmed/37859645 http://dx.doi.org/10.1177/20406207231202306 |
Ejemplares similares
-
Surgical outcomes in patients with haemophilia A or B receiving extended half‐life recombinant factor VIII and IX Fc fusion proteins: Real‐world experience in the Nordic countries
por: Lehtinen, Anna‐Elina, et al.
Publicado: (2022) -
High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study
por: Steen Carlsson, Katarina, et al.
Publicado: (2023) -
Pain, depression and anxiety in people with haemophilia from three Nordic countries: Cross‐sectional survey data from the MIND study
por: Steen Carlsson, Katarina, et al.
Publicado: (2022) -
Griding The Nordic Supercomputing Infrastructure
por: Ynnerman, Bo Anders
Publicado: (2004) -
Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
por: Augustsson, Cecilia, et al.
Publicado: (2020)